A 3-day-old term neonate born to an O-positive mother presents with clinical jaundice. The mother is O-negative and unsensitized (indirect Coombs test negative at delivery). The infant's total serum bilirubin is 14 mg/dL. Which investigation is most appropriate to confirm hemolytic disease and guide management?

Question

Accepted Answer

D. Direct antiglobulin test (DAT/Coombs) on infant red blood cells. ## Investigation of Choice for Suspected Hemolytic Jaundice ### Clinical Context This neonate has risk factors for hemolytic disease: - ABO incompatibility (O-negative mother, O-positive infant) - Early-onset jaundice (day 3) - Elevated bilirubin requiring intervention ### Why Direct Antiglobulin Test (DAT) is Correct **Key Point:** The DAT detects **IgG antibodies bound directly to the surface of fetal/neonatal red blood cells**, confirming in-vivo hemolysis. **High-Yield:** DAT is the **gold standard confirmatory test** for hemolytic disease of the newborn (HDN). A positive DAT in the presence of clinical jaundice and elevated bilirubin establishes hemolysis as the etiology. **Clinical Pearl:** Even though the mother's indirect Coombs was negative (unsensitized), ABO incompatibility can still cause hemolysis because naturally occurring maternal IgG anti-A and anti-B antibodies cross the placenta. The infant's DAT will be positive. ### Interpretation Algorithm ```mermaid flowchart TD A[Neonatal jaundice + risk factors]:::outcome --> B{DAT positive?}:::decision B -->|Yes| C[Hemolytic disease confirmed]:::outcome C --> D[Check reticulocyte count
and LDH/indirect bili]:::action B -->|No| E[Non-hemolytic jaundice
e.g., physiologic, breast milk]:::outcome E --> F[Assess phototherapy
threshold by age]:::action ``` ### Comparison of Tests in Hemolytic Jaundice | Investigation | Specificity | Timing | Role | |---|---|---|---| | **DAT (Direct Coombs)** | Confirms hemolysis | Stat | Gold standard; detects RBC-bound antibodies | | Indirect Coombs (maternal) | Screens for alloimmunization | Antenatal/delivery | Negative does NOT exclude ABO incompatibility | | Reticulocyte count | Reflects bone marrow response | Day 3–5 | Elevated in hemolysis; supports diagnosis | | Transcutaneous bilirubinometry | Non-invasive bilirubin estimate | Bedside | Screening tool; NOT diagnostic for hemolysis | | Peripheral smear | Morphology | Day 3+ | Shows spherocytes, polychromasia in hemolysis | **Key Point:** A **positive DAT + elevated bilirubin + clinical jaundice = hemolytic disease** until proven otherwise. [cite:Park 26e Ch 11] ![Neonatal Jaundice diagram](https://mmcphlazjonnzmdysowq.supabase.co/storage/v1/object/public/blog-images/explanation/3607.webp)

Answer

A. Reticulocyte count and peripheral blood smear

Answer

B. Transcutaneous bilirubinometry

Answer

C. Repeat indirect Coombs test on infant serum

Explanation

Investigation of Choice for Suspected Hemolytic Jaundice

Clinical Context

Why Direct Antiglobulin Test (DAT) is Correct

Interpretation Algorithm

Comparison of Tests in Hemolytic Jaundice

Practice similar questions

Join our NEET PG community

Investigation	Specificity	Timing	Role
DAT (Direct Coombs)	Confirms hemolysis	Stat	Gold standard; detects RBC-bound antibodies
Indirect Coombs (maternal)	Screens for alloimmunization	Antenatal/delivery	Negative does NOT exclude ABO incompatibility
Reticulocyte count	Reflects bone marrow response	Day 3–5	Elevated in hemolysis; supports diagnosis
Transcutaneous bilirubinometry	Non-invasive bilirubin estimate	Bedside	Screening tool; NOT diagnostic for hemolysis
Peripheral smear	Morphology	Day 3+	Shows spherocytes, polychromasia in hemolysis